For Investors

Sales of Olainfarm Last Year Increased by at Least 4%

on January 16, 2018

Preliminary consolidated results of JSC Olainfarm for December 2017 show that sales have reached 10.08 million euros, which represents a reduction by 2% compared to December 2016. The biggest sales increase was achieved in Ukraine, where sales grew by 700%, and in Belarus, where sales increased by 329%. The biggest sales reduction was experienced in Kyrgyzstan, where sales shrunk by 36%, while sales to Kazakhstan shrunk by 32%. During December 2017, significant shipments were also made to Uzbekistan. Major sales markets of Olainfarm group during December 2017 were Russia, Latvia and Ukraine.

December 2017, consolidated sales Sales, thsnd. EUR Changes to December 2016 Share in total sales
Russia 4 471 -12% 44%
Latvia 2 682 -2% 27%
Ukraine 840 700% 8%
Belarus 307 329% 3%
Tajikistan 218 -15% 2%
Kazakhstan 193 -32% 2%
Uzbekistan 176 NA 2%
Lithuania 126 19% 1%
Georgia 124 -7% 1%
Kyrgyzstan 113 -36% 1%
Other 826 -39% 8%
Total 10 076 -2% 100%

 

Sales of pharmacy chain of Latvijas aptieka during December 2017 were 2 million euros, which represents an increase by 21% compared to sales this company made in December 2016. Sixty-nine pharmacies were operating during this period. Sales of Silvanols during December 2017 were 0.4 million euros, which represents a reduction by 18% compared to December 2016. During December, Silvanols sold its products to nine European countries and with the help of JSC Olainfarm also to Belarus, Russia, Azerbaijan and Kosovo. Sales of Tonus Elast during December 2017 were 0.8 million euros, which represents a reduction by 26% compared to December 2016. The sales were made to 21 countries in three continents.

According to preliminary numbers, consolidated sales of JSC Olainfarm in 2017 reached 114.04 million euros, which represents an increase by 4% compared to 2016. The biggest sales increases have been achieve in Germany, where sales grew by 103% and The Netherlands, where sales grew by 57%. Biggest sales reductions were experienced in Ukraine, Where sales shrunk by 21% and Uzbekistan, where sales shrunk by 15%. Major sales markets of Olainfarm group in 2017 were Russia, Latvia, Ukraine and Belarus. Companies of the group made sales to 61 countries in five continents.

Consolidated sales, 2017 Sales, Thsnd. EUR Changes to 2016 Share in total sales
Russia 39 850 6% 35%
Latvia 28 492 7% 25%
Ukraine 10 936 -21% 10%
Belarus 8 939 21% 8%
The Netherlands 3 856 57% 3%
Kazakhstan 3 116 -2% 3%
Uzbekistan 1 869 -15% 2%
Germany 1 718 103% 2%
Lithuania 1 508 13% 1%
Poland 1 376 -5% 1%
Other 12 382 -5% 11%
Total 114 042 4% 100%

 

Sales of Latvijas aptieka in 2017 reached 21.6 million euros, which represents an increase by 16% compared to 2016. Sales of Silvanols in 2017 were 5.2 million euros, which represents a reduction by 3% compared to 2016, where sales of Silvanols were 5.4 million euros. Products of Silvanols were sold to twelve European countries and with the help of JSC Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia, Kosovo and Azerbaijan. Sales of Tonus Elast in 2017 were 8.5 million euros, and its products were sold to 38 countries in four continents.

According to preliminary unconsolidated data, sales of JSC Olainfarm in December 2017 were 8.08 million euros, which represents an increase by 4% compared to December 2016. The biggest sales increase was achieved in Ukraine, where sales grew by 625%. Sales to Belarus increased by 382%, while sales to Lithuania increased by 50%. The biggest sales reduction was experienced in Kazakhstan where sales shrunk by 54%. During December 2017, JSC Olainfarm also made significant shipments to Uzbekistan and Bulgaria. The biggest sales markets of JSC Olainfarm in December 2017 were Russia, Latvia and Ukraine. In total during this period, products of JSC Olainfarm were sold to 28 countries.

December 2017, unconsolidated sales Sales, Thsnd. EUR Changes to December 2016 Share in total sales
Russia 4 181 -11% 52%
Latvia 1 410 20% 17%
Ukraine 761 625% 9%
Belarus 245 382% 3%
Tajikistan 212 -13% 3%
Uzbekistan 176 NA 2%
Lithuania 120 50% 1%
Kazakhstan 112 -54% 1%
Bulgaria 104 NA 1%
Kyrgyzstan 99 -26% 1%
Other 655 -36% 8%
Total 8 075 4% 100%

 

According to preliminary unconsolidated results, sales of JSC Olainfarm in 2017 reached 91.97 million euros, which is comparable to the sales company made in 2016. The biggest sales increase in 2017 was achieved in Germany, where sales grew by 100%, while sales to The Netherlands increased by 57%. The biggest sales reduction was experienced in Ukraine, where sales shrunk by 28%. The major sales markets of JSC Olainfarm during this period were Russia, Latvia, Ukraine and Belarus. In total during 2017 products of JSC Olainfarm were sold to 51 countries in five continents.

2017, unconsolidated sales Sales, thsnd. EUR Changes to 2016 Share in total sales
Russia 36 471 1% 40%
Latvia 14 815 10% 16%
Ukraine 10 655 -28% 12%
Belarus 8 764 20% 10%
The Netherlands 3 856 57% 4%
Kazakhstan 2 094 -19% 2%
Uzbekistan 1 869 -15% 2%
Germany 1 670 100% 2%
Lithuania 1 281 16% 1%
Turkmenistan 1 246 17% 1%
Other 9 247 -8% 10%
Total 91 968 0% 100%

 

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in 2017 the company has met 96% of annual target for unconsolidated sales and 90% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

read more
SigitaSales of Olainfarm Last Year Increased by at Least 4%

Recording of the Third Quarter 2017 Investor Conference Webinar

on January 15, 2018

On January 11 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of third quarter 2017 and informed about the other recent activities within the company.

During the webinar, Salvis Lapiņš received a question on the amount of receivables overdue for 90 and more days that are unprovided for. The amount totaled 1.4 million euros as of October 1st, 2017.

The recorded JSC Olainfarm webinar is available online: http://ej.uz/OLF_Q3_2017, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement: http://ej.uz/OLF_Q32017_EN.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Eva DombrovskaRecording of the Third Quarter 2017 Investor Conference Webinar

Olainfarm Holds Third Quarter 2017 and Latest Corporate News Investor Conference Webinar

on January 11, 2018

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on January 11, 2018 at 16:00 (EET). To join the webinar please follow the instructions below.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm latest activities and analyze the financial results of the third quarter 2017. During the webinar the enclosed presentation will be presented: Webinar Presentation: 3rd quarter and 9 months of 2017

After the presentation investors are welcome to ask questions.

What is a webinar?
Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.

How to join the webinar?
All you need is a computer with internet connection and headphones.

To join the webinar, we invite you to register via http://ej.uz/OLFQ3.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds. For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/

Join the webinar and be the first one to hear the news!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm Holds Third Quarter 2017 and Latest Corporate News Investor Conference Webinar

Sales of Olainfarm in November shrinks by 10%

on December 20, 2017

Preliminary consolidated results of JSC Olainfarm for November 2017 show that total sales of the company have reached 10.07 million euros, which represents a reduction by 10% compared to the same period of 2016. The biggest sales increase has been achieved in Ukraine, where it increased by 209%. Sales to Kyrgyzstan increased by 149%, but sales to Uzbekistan increased by 133%. Biggest sales reduction took place in Kazakhstan, where they shrunk by 65%. During November 2017 JSC Olainfarm also made significant shipments to Turkmenistan. Major sales markets of the Group during November 2017 were Russia, Latvia and Ukraine.

November 2017, consolidated sales Sales, thsnd. EUR Changes to November 2016 Share in total sales
Russia 3 563 -33% 35%
Latvia 2 643 5% 26%
Ukraine 1 542 209% 15%
Belarus 520 14% 5%
Uzbekistan 297 133% 3%
Kazakhstan 191 -65% 2%
Germany 158 36% 2%
Turkmenistan 143 NA 1%
Lithuania 122 -25% 1%
Kyrgyzstan 116 149% 1%
Other 771 -45% 8%
Total 10 066 -10% 100%

 

Sales of Latvijas aptieka during November were 1.9 million euros, which represents an increase by 18% compared to November of 2016. Sixty – nine pharmacies were operating during this period. Sales of Silvanols in November 2017 were 0.46 million euros, which represents a reduction by 28% compared to the same period of last year. During November, Silvanols was selling its products to nine European countries and with the assistance from JSC Olainfarm also to Belarus, Russia, Azerbaijan and Kosovo. Sales of Tonus Elast during November 2017 were 0.9 million euros, which represents an increase by 15% compared to November 2016. Its products were sold to 20 countries in three continents.

According to preliminary consolidated results sales of eleven months of 2017 reached 105.19 million euros, which represents an increase by 5% compared to eleven months of 2016. The biggest sales increase during this period was achieved in Germany, where sales grew by 106%, while sales to The Netherlands increased by 92%. The biggest sales reduction was experienced in Ukraine, where sales shrunk by 27%. Major sales markets of the Group during this period were Russia, Latvia, Ukraine and Belarus. Products of the group were sold to 61 countries in five continents.

11 months of 2017, consolidated sales Sales, thsnd. EUR Changes to 11 months of 2016 Share in total sales
Russia 35 379 9% 34%
Latvia 26 994 12% 26%
Ukraine 10 096 -27% 10%
Belarus 8 734 19% 8%
The Netherlands 3 856 92% 4%
Kazakhstan 2 923 0% 3%
Germany 1 712 106% 2%
Uzbekistan 1 694 -23% 2%
Lithuania 1 382 14% 1%
Poland 1 281 -3% 1%
Other 11 138 -5% 11%
Total 105 189 5% 100%

 

During eleven months period, sales of Latvijas aptieka reached 19.6 million euros, which represents an increase by 15% compared to the same period of last year. Sales of Silvanols during this period shrunk by 4% and reached 4.7 million euros. Silvanols sold its products to twelve European countries and with assistance from JSC Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia, Kosovo and Azerbaijan. Sales of Tonus Elast during eleven months were 7.7 million euros, and its products were sold to 38 countries in four continents.

According to preliminary unconsolidated results, sales of JSC Olainfarm during November 2017 reached 7.97 million euros, which represents a reduction by 12% compared to November 2016. The biggest sales increase during this period was achieved in Ukraine, where sales grew by 223%. Sales to Uzbekistan increased by 133%, sales to Kyrgyzstan increased by 104%. The biggest sales reduction during November was experienced in Kazakhstan, where sales shrunk by 76%. During November 2017, JSC Olainfarm also made significant shipments to Turkmenistan. Major sales markets of JSC Olainfarm during this period were Russia, Ukraine, Latvia and Belarus. In total products of Olainfarm were sold to 23 countries in Europe and Asia.

November 2017, unconsolidated sales Sales, thsnd. EUR Changes to November 2016 Share in total sales
Russia 3 194 -37% 40%
Ukraine 1 542 223% 19%
Latvia 1 370 9% 17%
Belarus 502 13% 6%
Uzbekistan 297 133% 4%
Turkmenistan 143 NA 2%
Germany 137 22% 2%
Lithuania 118 -14% 1%
Kazakhstan 115 -76% 1%
Kyrgyzstan 95 104% 1%
Other 454 -52% 6%
Total 7 967 -12% 100%

 

According to preliminary unconsolidated results, sales of JSC Olainfarm in eleven months of 2017 were 84 million euros, which represents a reduction by 1% compared to eleven months of 2016. The biggest sales increase during this period was achieved in Germany, where sales grew by 103% and The Netherlands, where the sales grew by 92%. The biggest sales reduction was experienced in Ukraine, where sales shrunk by 27% and Uzbekistan, where sales shrunk by 23%. Major sales markets of JSC Olainfarm during this period were Russia, Latvia, Ukraine and Belarus. In total during eleven months period products of JSC Olainfarm were sold to 50 countries in five continents.

11 months of 2017, unconsolidated sales Sales, thsnd. EUR Changes to 11 months of 2016 Share in total sales
Russia 32 290 3% 38%
Latvia 13 404 9% 16%
Ukraine 9 894 -27% 12%
Belarus 8 622 19% 10%
The Netherlands 3 856 92% 5%
Kazakhstan 1 982 -15% 2%
Uzbekistan 1 694 -23% 2%
Germany 1 665 103% 2%
Turkmenistan 1 167 9% 1%
Lithuania 1 161 13% 1%
Other 8 261 -9% 10%
Total 83 996 1% 100%

 

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in eleven months of 2017 the company has met 88% of annual target for unconsolidated sales and 83% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

 

read more
SigitaSales of Olainfarm in November shrinks by 10%

Sales of Olainfarm in October Shrink by 7%

on November 15, 2017

Preliminary consolidated results of JSC Olainfarm for October 2017 show that company’s sales have reached 9.51 million euros, which represents reduction by 7% compared to the same period of 2016. The biggest sales increase during this period was achieved in Poland, where it grew by 623%. Sales to Moldova increased by 180%. Significant shipments during this period were also made to Tajikistan. Major sales markets of Olainfarm group during October 2017 were Russia, Latvia and Ukraine.

October 2017, consolidated sales Sales, thsnd. EUR Changes to October 2016 Share in total sales
Russia 3 434 -18% 36%
Latvia 2 754 18% 29%
Ukraine 1 143 3% 12%
Belarus 518 -5% 5%
Germany 249 -11% 3%
Poland 216 623% 2%
Tajikistan 176 NA 2%
Moldova 149 180% 2%
Lithuania 136 40% 1%
Georgia 105 7% 1%
Other 630 -55% 7%
Total 9 510 -7% 100%

 

Sales of pharmacies of Latvijas aptieka in October 2017 were 2.02 million euros, which represents an increase by 25% compared to the same period of last year. Sixty-nine pharmacies were operating during October. Sales of Silvanols in October 2017 were 0.4 million euros, which represents a reduction by 25% compared to the same period of 2016. Silvanols was selling its products in six European countries. Sales of Tonus Elast in October were 0.62 million euros, which represents a reduction by 29% compared to October 2016. Tonus Elast sold its products in 15 countries in three continents.

In ten months of 2017, according to the preliminary results, the consolidated sales of JSC Olainfarm reached 95.11 million euros, which represents an increase by 7% compared to ten months of 2016. The biggest sales increase during this period was achieved in Germany, where sales increased by 118%. Sales to The Netherlands increased by 92%. Biggest sales reduction took place in Ukraine, where sales shrunk by 35%. The major sales markets of Olainfarm group during this period were Russia, Latvia, Ukraine and Belarus.

10 months of 2017, consolidated sales Sales, thsnd. EUR Changes to 10 months of 2016 Share in total sales
Russia 31 816 17% 33%
Latvia 24 359 13% 26%
Ukraine 8 554 -35% 9%
Belarus 8 214 20% 9%
The Netherlands 3 831 92% 4%
Kazakhstan 2 733 16% 3%
Germany 1 554 118% 2%
Uzbekistan 1 397 -33% 1%
Lithuania 1 265 15% 1%
Poland 1 222 11% 1%
Other 10 168 -3% 11%
Total 95 113 7% 100%

 

Sales of pharmacies of Latvijas aptieka in 10 months of 2017 reached 17.7 million euros, which represents an increase by 14% compared to ten months of 2016.  Sales of Silvanols during this ten months period have reached 4.3 million euros, which represents an increase by 2%. Products of Silvanols are sold to twelve European countries. Sales of Tonus Elast in ten months was 6.8 million euros, and the company sold its products to 37 countries in four continents.

According to unconsolidated preliminary results, sales of JSC Olainfarm in October 2017 were 7.63 million euros, which represents a reduction by 5% compared to October 2016. The biggest sales increase was achieved in Poland, where sales grew by 552%. Sales to Lithuania increase by 58%. During October 2017, the company also made significant shipments to Tajikistan and Albania. Biggest sales reduction was experienced in Kazakhstan, where sales shrunk by 35%. Major markets of the company during October 2017 were Russia, Latvia, Ukraine and Belarus. During October 2017 JSC Olainfarm sold its products to 27 countries in two continents.

October 2017, unconsolidated sales Sales, thsnd. EUR Changes to October 2016 Share in total sales
Russia 3 151 -18% 41%
Latvia 1 447 33% 19%
Ukraine 1 125 3% 15%
Belarus 518 -1% 7%
Germany 236 -16% 3%
Poland 187 552% 2%
Tajikistan 176 NA 2%
Lithuania 115 58% 2%
Kazakhstan 93 -35% 1%
Albania 77 NA 1%
Other 502 -47% 7%
Total 7 627 -5% 100%

 

According to preliminary unconsolidated results, sales of JSC Olainfarm in ten months of 2017 reached 76.04 million euros, which represents an increase by 3% compared to ten months of 2016. The biggest sales increase during this period was achieved in Germany, where sales grew by 116%. Sales to The Netherlands increased by 92%. Biggest sales reduction was experienced in Ukraine, where it shrunk by 36%. Biggest sales markets of JSC Olainfarm during this period were Russia, Latvia, Ukraine and Belarus. In total in ten months of 2017, JSC Olainfarm sold its products to 50 countries in five continents.

10 months of 2017, unconsolidated sales Sales, thsnd. EUR Changes to ten months of 2016 Share in total sales
Russia 29 096 10% 38%
Latvia 12 043 9% 16%
Ukraine 8 352 -36% 11%
Belarus 8 120 19% 11%
The Netherlands 3 831 92% 5%
Kazakhstan 1 868 0% 2%
Germany 1 528 116% 2%
Uzbekistan 1 397 -33% 2%
Lithuania 1 047 18% 1%
Turkmenistan 1 023 -4% 1%
Other 7 738 -4% 10%
Total 76 043 3% 100%

 

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in ten months of 2017 the company has met 79% of annual target for unconsolidated sales and 75% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

 

read more
SigitaSales of Olainfarm in October Shrink by 7%

Sales of Olainfarm in September Increase by 17%

on October 16, 2017

Preliminary consolidated results of JSC Olainfarm for September 2017 show that sales made during this month reached 9.63 million euros, which represents an increase by 17% compared to September 2016. The biggest sales increase was achieved in Uzbekistan, where sales grew by 388%. Sales to Albania grew by 232%, sales to Germany grew by 159%, sales to Russia grew by 69% but sales to Ukraine increased by 54%. The biggest sales reduction happened in The Netherlands, where sales shrunk by 73%. Major sales markets of the Group during September 2017 were Russia, Latvia, Ukraine and Belarus.

September 2017, consolidated sales Sales, thsnd. EUR Changes to September 2016 Share in total sales
Russia 3 447 69% 36%
Latvia 2 728 13% 28%
Ukraine 1 021 54% 11%
Belarus 674 24% 7%
Kazakhstan 375 -18% 4%
The Netherlands 146 -73% 2%
Uzbekistan 144 388% 1%
Lithuania 141 37% 1%
Germany 129 159% 1%
Albania 111 232% 1%
Other 712 -46% 7%
Total 9 628 17% 100%

 

Sales of pharmacies of Latvijas aptieka during September 2017 were 1.94 million euros, which represents an increase by 21% compared to September 2016. Sixty-nine pharmacies were operating during this period. Sales of Silvanols in September 2017 were 0.55 million euros, which represents a reduction by 13% compared to the same period of last year. During September 2017, Silvanols sold its products in four European countries and with the mediation of JSC Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia and Azerbaijan. Sales of Tonus Elast in September reached 0.74 million euros, which represents an increase by 40% compared to September 2016. Its products were sold to 16 countries in three continents.

According to preliminary consolidated results, sales of JSC Olainfarm group in nine months of 2017 reached 85.61 million euros, which represents an increase by 9% compared to nine months of 2016. The biggest sales increase during this period was achieved in Germany, where sales grew by 200%, but sales to The Netherlands increased by 133%. The biggest sales reduction was experienced in Ukraine where sales shrunk by 39%. Major sales markets of JSC Olainfarm group in nine months of 2017 were Russia, Latvia, Belarus and Ukraine.

9 months of 2017, consolidated sales Sales, thsnd. EUR Changes to 9 months of 2016 Share in total sales
Russia 28 382 23% 33%
Latvia 21 611 13% 25%
Belarus 7 696 22% 9%
Ukraine 7 412 -39% 9%
The Netherlands 3 814 133% 4%
Kazakhstan 2 640 30% 3%
Uzbekistan 1 397 -22% 2%
Germany 1 305 200% 2%
Lithuania 1 129 18% 1%
Turkmenistan 1 023 -4% 1%
Other 9 200 -8% 11%
Total 85 609 9% 100%

 

Sales of pharmacies of Latvijas aptieka in nine months of 2017 reached 15.7 million euros, which represents an increase by 13% compared to nine months of 2016. Sales of Silvanols in nine months reached 3.89 million euros, which represents an increase by 6% compared to 9 months of 2016. Products of Silvanols were sold to twelve European countries and with the help of JSC Olainfarm also to Kazakhstan, Lithuania, Belarus, Russia, Armenia, Mongolia and Azerbaijan. Sales of Tonus Elast in nine months reached 6.17 million euros and its products were sold to 37 countries in four continents.

According to preliminary unconsolidated results, sales of JSC Olainfarm in September 2017 were 7.55 million euros, which represents an increase by 17% compared to September 2016. The biggest sales increase was achieved in Uzbekistan, where sales grew by 388%. Sales to Albania increased by 232%, sales to Germany increased by 161%, sales to Lithuania increases by 81%, sales to Ukraine increased by 63% and sales to Russia increased by 59%. Biggest sales reduction was experienced in the Netherlands, where sales shrunk by 73% and in Kazakhstan, where sales shrunk by 69%. Biggest sales markets during September 2017 were Russia, Latvia, Ukraine and Belarus. During September 2017, products of JSC Olainfarm were sold to 32 countries in Asia and Europe.

September 2017, unconsolidated sales Sales, thsnd. EUR Changes to September 2016 Share in total sales
Russia 3 255 59% 43%
Latvia 1 334 9% 18%
Ukraine 1 021 63% 14%
Belarus 674 24% 9%
The Netherlands 146 -73% 2%
Uzbekistan 144 388% 2%
Lithuania 135 81% 2%
Germany 129 161% 2%
Kazakhstan 121 -69% 2%
Albania 111 232% 1%
Other 482 -46% 6%
Total 7 552 17% 100%

 

According to preliminary unconsolidated results of JSC Olainfarm for nine months of 2017, sales of the company during this period reached 68.42 million euros, which represents an increase by 4% compared to nine months of 2016. The biggest sales increase was achieved in Germany, where sales increased by 202% and in The Netherlands, where sales grew by 133%. Biggest sales reduction was experienced in Ukraine, where sales shrunk by 40%. Major sales markets of JSC Olainfarm during this period were Russia, Latvia, Belarus and Ukraine. In total, during nine months of 2017, products of JSC Olainfarm were sold to 48 countries in five continents.

9 months of 2017, unconsolidated sales Sales, thsnd. EUR Changes to nine months of 2016 Share in total sales
Russia 25 946 15% 38%
Latvia 10 602 7% 15%
Belarus 7 602 21% 11%
Ukraine 7 228 -40% 11%
The Netherlands 3 814 133% 6%
Kazakhstan 1 774 3% 3%
Uzbekistan 1 397 -22% 2%
Germany 1 292 202% 2%
Turkmenistan 1 023 -4% 1%
Italy 954 36% 1%
Other 6 789 -14% 10%
Total 68 421 4% 100%

 

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in nine months of 2017 the company has met 71% of annual target for unconsolidated sales and 67% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

 

read more
SigitaSales of Olainfarm in September Increase by 17%

Sales of Olainfarm in August Increase by 19%

on September 15, 2017

Preliminary consolidated results of Olainfarm for August 2017 show that sales of the group reached 8.04 million euros, which represents an increase by 19% compared to August of 2016. The biggest sales increase was achieved in Tajikistan, where sales grew by 349%. Sales to Germany grew by 110%; sales to Russia grew by 93%, sales to Belarus increased by 63%. Biggest sales reduction happened in Ukraine where sales shrunk by 49%. During August 2017, the Group also made significant shipments to Turkmenistan and The Netherlands. Major sales markets of the group during this period were Russia, Latvia and Belarus.

 

August 2017, consolidated sales Sales, thsnd. EUR Changes to August 2016 Share in total sales
Russia 2 633 93% 33%
Latvia 2 342 7% 29%
Belarus 807 63% 10%
Ukraine 493 -49% 6%
Kazakhstan 245 17% 3%
Uzbekistan 216 -28% 3%
Turkmenistan 194 NA 2%
Germany 159 110% 2%
The Netherlands 120 NA 1%
Tajikistan 101 349% 1%
Other 727 -37% 9%
Total 8 037 19% 100%

 

Sales of pharmacies of Latvijas Aptieka during August 2017 were 1.83 million euros, which represents an increase by 24% compared to August 2016. Sixty-eight pharmacies were operating during this period.  Sales of Silvanols during August were 0.38 million euros, which represents an increase by 6% compared to 2016.  In August 2017, Silvanols sold its products in seven European countries and, with the assistance from JSC Olainfarm to Kazakhstan, Belarus and Russia.  Sales of Tonus Elast during August 2017 reached .73 million euros, which represents a reduction by 4% compared to August 2016. Products of Tonus Elast were sold to 19 countries in three continents.

 

According to preliminary numbers, consolidated sales of Olainfarm group in eight months of 2017 reached 76.39 million euros, which represents an increase by 9% compared to eight months of 2016.  The biggest sales increase was achieved in The Netherlands, where sales grew by 236%.  Sales to Germany increased by 206%, sakes to Kazakhstan increased by 44% but sales to Italy increased by 43%. Biggest reduction of sales took place in Ukraine, where sales shrunk by 44%.  Major sales markets of Olainfarm group in eight months were Russia, Latvia, Belarus and Ukraine.

 

8 months of 2017, consolidated sales Sales, thsnd. EUR Changes to 8 months of 2016 Share in total sales
Russia 24 935 19% 33%
Latvia 19 306 17% 25%
Belarus 7 023 22% 9%
Ukraine 6 391 -44% 8%
The Netherlands 3 668 236% 5%
Kazakhstan 2 265 44% 3%
Uzbekistan 1 253 -28% 2%
Germany 1 176 206% 2%
Turkmenistan 1 023 -4% 1%
Italy 1 003 43% 1%
Other 8 347 -9% 11%
Total 76 390 9% 100%

 

Sales of pharmacies of Latvijas aptieka in eight months of 2017 were 13.8 million euros, which represents an increase by 12% compared to eight months of 2016. Sales of Silvanols during this period were 3.3 million euros, which represents an increase by 6% compared to eight months of 2016 when this company made sales of 3.1 million euros. Products of Silvanols were sold to twelve European countries and with the help from JSC Olainfarm to Lithuania, Russia, Azerbaijan, Belarus, Kazakhstan and Armenia.  Sales of Tonus Elast in eight months were 5.4 million euros and its products were sold to 37 countries in four continents.

 

According to unconsolidated preliminary results, sales of JSC Olainfarm in August 2017 were 6.07 million euros, which represents an increase by 24% compared to August of 2016. The biggest sales increase was achieved in Tajikistan, where sales grew by 349%. Sales to Germany increased by 112%, sale to Russia increased by 66%, sales to Kazakhstan increased by 65% but sales to Belarus increased by 61%.  The biggest sales reduction took place in Ukraine, where sales shrunk by 58%.  During August 2017, JSC Olainfarm also made significant shipments to Turkmenistan and The Netherlands. Major sales markets of JSC Olainfarm during this period were Russia, Latvia, Belarus and Ukraine. In august 2017, products of JSC Olainfarm were sold to 25 countries in two continents.

August 2017, unconsolidated sales Sales, thsnd. EUR Changes to August 2016 Share in total sales
Russia 2 267 66% 37%
Latvia 1 108 6% 18%
Belarus 778 61% 13%
Ukraine 402 -58% 7%
Uzbekistan 216 -28% 4%
Kazakhstan 200 65% 3%
Turkmenistan 194 NA 3%
Germany 155 112% 3%
The Netherlands 120 NA 2%
Tajikistan 101 349% 2%
Other 533 4% 9%
Total 6 074 24% 100%

 

According to preliminary unconsolidated results, sales of JSC Olainfarm in eight months of 2017 were 60.87 million euros, which represents and increase by 2% compared to the same period one year ago. The biggest sales increase during this period was achieved in The Netherlands, where sales increased by 249%, while sales to Germany increased by 207%.  Biggest sales reduction was experienced in Ukraine, where sales shrunk by 46%.  Major sales markets of JSC Olainfarm during these eight months were Russia, Latvia, Belarus and Ukraine.  In total during this eight months period JSC Olainfarm sold its products to 46 countries in five continents.

 

Eight months of 2017, unconsolidated sales Sales, thsnd. EUR Changes to 8 months of 2016 Share in total sales
Russia 22 691 10% 37%
Latvia 9 271 7% 15%
Belarus 6 929 21% 11%
Ukraine 6 207 -46% 10%
The Netherlands 3 668 249% 6%
Kazakhstan 1 654 24% 3%
Uzbekistan 1 253 -28% 2%
Germany 1 163 207% 2%
Turkmenistan 1 023 -4% 2%
Italy 953 36% 2%
Other 6 061 -13% 10%
Total 60 873 2% 100%

 

General meeting of shareholders of JSC Olainfarm held on June 1, 2017 approved operating plan of the company, providing that unconsolidated sales of the company in 2017 will reach 96 million euros, while consolidated sales of the company will reach 127 million euros. According to these preliminary sales numbers, in eight months of 2017 the company has met 63% of annual target for unconsolidated sales and 60% of annual target for consolidated sales.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rūpnīcu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Eva DombrovskaSales of Olainfarm in August Increase by 19%

Recording of the Second Quarter 2017 Investor Conference Webinar

on September 13, 2017

On September 11 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of second quarter 2017 and informed about the other recent activities within the company.

The recorded JSC Olainfarm webinar is available online: ej.uz/OLF_Q22017_rec, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement: ej.uz/OLF_Q22017_EN.
Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
Salvis Lapins
JSC Olainfarm Member of the Management
Board Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Eva DombrovskaRecording of the Second Quarter 2017 Investor Conference Webinar

Olainfarm Holds a Webinar and Announces Updated Profit Forecasts

on September 11, 2017

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 11, 2017 at 16:00 (EEST). To join the webinar please follow the instructions below.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm latest activities and analyze the financial results of the second quarter 2017. After the presentation investors are welcome to ask questions.

Among other things, Mr Lapiņš will inform about the updated profit forecast for 2017 for the Company and the Group. The management now expects that unconsolidated profit of Olainfarm will reach 11 million euros, while consolidated profit will be around 13.5 million euros. These projections are based on assumption that foreign exchange fluctuations will not leave any important impact on profitability.

The attached presentation will be presented during the webinar: Webinar Presentation: 2nd quarter of 2017

What is a webinar?
Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.

How to join the webinar?
All you need is a computer with internet connection and headphones.

To join the webinar, we invite you to register via http://ej.uz/OLF_2017Q2.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.

For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/

Join the webinar and be the first one to hear the news!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
SigitaOlainfarm Holds a Webinar and Announces Updated Profit Forecasts

Olainfarm will hold Second Quarter 2017 Investor Conference Webinar

on September 5, 2017

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 11, 2017 at 16:00 (EEST). To join the webinar please follow the instructions below.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm latest activities and analyze the financial results of the second quarter 2017.

After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance until September 10 to e-mail: eva.dzerve@nasdaq.com.

What is a webinar? Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.

How to join the webinar? All you need is a computer with internet connection and headphones.

To join the webinar, we invite you to register via http://ej.uz/OLF_2017Q2.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds. For more information on webinar service please visit: http://www.nasdaqbaltic.com/en/products-services/webinars-3/

Join the webinar and be the first one to hear the news!

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Eva DombrovskaOlainfarm will hold Second Quarter 2017 Investor Conference Webinar